OptimizeRx CorporationOPRXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+19.6%
5Y CAGR+15.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+19.6%/yr
vs +27.1%/yr prior
5Y CAGR
+15.9%/yr
Recent acceleration
Acceleration
-7.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$40.16M+22.6%
2024$32.75M+14.4%
2023$28.62M+21.9%
2022$23.48M-8.5%
2021$25.65M+33.6%
2020$19.21M+109.7%
2019$9.16M+1.8%
2018$9.00M+45.8%
2017$6.17M+81.0%
2016$3.41M-